Stealth BioTherapeutics Corp - ADR

NASDAQ:MITO   3:59:40 PM EDT
1.49
-0.04 (-2.61%)
Other Pre-Announcement

Stealth BioTherapeutics Reports Q1 Loss Per Share Of $0.01

Published: 05/18/2021 11:41 GMT
Stealth BioTherapeutics Corp - ADR (MITO) - Stealth Biotherapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights.
Q1 Loss per Share $0.01.
Cash and Cash Equivalents Were $32.1 Million at March 31, 2021, Compared to $32.8 Million at December 31, 2020.
Expects Current Cash Position Will Be Sufficient to Enable It to Fund Its Planned Operations Into Q2 of 2022.